Real-World Treatment Patterns and Outcomes Among Multiple Myeloma Patients with Asthma and COPD in the United States

INTRODUCTION: Multiple myeloma (MM) is the second most frequent hematologic malignancy after lymphoma, contributing to approximately 10% of all hematologic malignancies. The prognosis of patients with MM is impacted by the heterogeneity of the disease, with worse outcomes reported in patients classi...

Descripción completa

Detalles Bibliográficos
Autores principales: Rice, Megan S., Naeger, Sarah, Singh, Erin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8140164/
https://www.ncbi.nlm.nih.gov/pubmed/33728584
http://dx.doi.org/10.1007/s40487-021-00146-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8140164/
https://www.ncbi.nlm.nih.gov/pubmed/33728584
http://dx.doi.org/10.1007/s40487-021-00146-4

Ejemplares similares